Steve Deacon

2.1k total citations · 1 hit paper
41 papers, 1.7k citations indexed

About

Steve Deacon is a scholar working on Experimental and Cognitive Psychology, Molecular Biology and Cognitive Neuroscience. According to data from OpenAlex, Steve Deacon has authored 41 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Experimental and Cognitive Psychology, 14 papers in Molecular Biology and 14 papers in Cognitive Neuroscience. Recurrent topics in Steve Deacon's work include Sleep and related disorders (14 papers), Sleep and Wakefulness Research (14 papers) and Bone Metabolism and Diseases (14 papers). Steve Deacon is often cited by papers focused on Sleep and related disorders (14 papers), Sleep and Wakefulness Research (14 papers) and Bone Metabolism and Diseases (14 papers). Steve Deacon collaborates with scholars based in United Kingdom, Japan and Denmark. Steve Deacon's co-authors include J. A. Tredger, John Wright, Ruan Elliott, LM Morgan, V. Marks, Joséphine Arendt, S. Hampton, L. Morgan, J. English and Richard Eastell and has published in prestigious journals such as The Journal of Urology, Journal of Bone and Mineral Research and SLEEP.

In The Last Decade

Steve Deacon

41 papers receiving 1.6k citations

Hit Papers

Glucagon-like peptide-1(7–36)amide and glucose-dependent ... 1993 2026 2004 2015 1993 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steve Deacon United Kingdom 20 653 452 425 403 375 41 1.7k
Rafael Luboshitzky Israel 22 618 0.9× 250 0.6× 430 1.0× 714 1.8× 303 0.8× 59 1.8k
Anne Caufriez Belgium 21 423 0.6× 237 0.5× 265 0.6× 678 1.7× 282 0.8× 60 1.4k
Mira Dalal Germany 15 301 0.5× 262 0.6× 303 0.7× 157 0.4× 252 0.7× 21 1.6k
Agnieszka Ziółkowska Poland 25 616 0.9× 94 0.2× 312 0.7× 280 0.7× 175 0.5× 80 1.6k
Ayman M. Arafat Germany 25 288 0.4× 87 0.2× 669 1.6× 1.1k 2.7× 109 0.3× 52 2.2k
M. L’Hermite Belgium 22 212 0.3× 83 0.2× 158 0.4× 792 2.0× 96 0.3× 104 1.6k
Agatha A. van der Klaauw Netherlands 27 386 0.6× 61 0.1× 426 1.0× 1.2k 3.0× 81 0.2× 49 2.0k
Megan E. Osler Sweden 21 130 0.2× 119 0.3× 660 1.6× 137 0.3× 95 0.3× 25 1.7k
Mohammad Ghatei United Kingdom 19 539 0.8× 148 0.3× 273 0.6× 214 0.5× 228 0.6× 40 1.4k
Wenyu Huang United States 17 679 1.0× 155 0.3× 491 1.2× 227 0.6× 145 0.4× 47 1.5k

Countries citing papers authored by Steve Deacon

Since Specialization
Citations

This map shows the geographic impact of Steve Deacon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve Deacon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve Deacon more than expected).

Fields of papers citing papers by Steve Deacon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steve Deacon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve Deacon. The network helps show where Steve Deacon may publish in the future.

Co-authorship network of co-authors of Steve Deacon

This figure shows the co-authorship network connecting the top 25 collaborators of Steve Deacon. A scholar is included among the top collaborators of Steve Deacon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steve Deacon. Steve Deacon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Eastell, Richard, et al.. (2013). Effect of ONO-5334 on Bone Mineral Density and Biochemical Markers of Bone Turnover in Postmenopausal Osteoporosis: 2-Year Results From the OCEAN Study. Journal of Bone and Mineral Research. 29(2). 458–466. 63 indexed citations
3.
Hashimoto, Yoshitaka, et al.. (2012). Serum and urine bone resorption markers and pharmacokinetics of the cathepsin K inhibitor ONO‐5334 after ascending single doses in post menopausal women. British Journal of Clinical Pharmacology. 74(6). 959–970. 14 indexed citations
4.
Hashimoto, Yoshitaka, et al.. (2011). Pharmacodynamic Effects on Biochemical Markers of Bone Turnover and Pharmacokinetics of the Cathepsin K Inhibitor, ONO‐5334, in an Ascending Multiple‐Dose, Phase 1 Study. The Journal of Clinical Pharmacology. 52(3). 306–318. 24 indexed citations
7.
Dijk, Derk‐Jan, et al.. (2009). Sex differences and the effect of gaboxadol and zolpidem on EEG power spectra in NREM and REM sleep. Journal of Psychopharmacology. 24(11). 1613–1618. 36 indexed citations
8.
Dijk, Derk‐Jan, et al.. (2007). Gaboxadol reduces the detrimental effects of traffic noise on sleep: A randomised, double-blind, placebo-controlled, parallel group study in healthy subjects. Surrey Research Insight Open Access (The University of Surrey). 1 indexed citations
9.
Deacon, Steve, et al.. (2007). Effect of Short-term Treatment With Gaboxadol on Sleep Maintenance and Initiation in Patients With Primary Insomnia. SLEEP. 30(3). 281–287. 38 indexed citations
10.
Svetnik, Vladimir, Junshui Ma, Keith A. Soper, et al.. (2007). Evaluation of Automated and Semi-Automated Scoring of Polysomnographic Recordings from a Clinical Trial Using Zolpidem in the Treatment of Insomnia. SLEEP. 30(11). 1562–1574. 45 indexed citations
11.
Walsh, James K., David Mayleben, Christine J. Guico‐Pabia, et al.. (2007). Efficacy of the selective extrasynaptic GABAA agonist, gaboxadol, in a model of transient insomnia: A randomized, controlled clinical trial. Sleep Medicine. 9(4). 393–402. 19 indexed citations
12.
Deacon, Steve, et al.. (2006). Gaboxadol improves sleep onset and maintenance and enhances low frequency components of NREM sleep EEG in a model of transient insomnia. View. 1 indexed citations
13.
Dijk, Derk‐Jan, John A. Groeger, Steve Deacon, & Neil Stanley. (2006). P.8.a.007 Association between individual differences in slow wave sleep, slow wave activity and sleep continuity in young, middle-aged and older men and women. European Neuropsychopharmacology. 16. S538–S538. 7 indexed citations
14.
Tinoco, Juan Carlos, Luis Huicho, Hugo Trujillo, et al.. (2000). Clinical and Bacteriologic Efficacy of Amoxycillin b.d. (45 mg/kg/day)VersusAmoxycillin t.d.s (40 mg/kg/day) in Children with Group A b-hemolytic Streptococcal Tonsillopharyngitis. Journal of Chemotherapy. 12(5). 396–405. 4 indexed citations
15.
Morgan, L., Joséphine Arendt, Deborah S. Owens, et al.. (1998). Effects of the endogenous clock and sleep time on melatonin, insulin, glucose and lipid metabolism. Journal of Endocrinology. 157(3). 443–451. 98 indexed citations
16.
Deacon, Steve, J. English, Jillian R. Tate, & Joséphine Arendt. (1998). Atenolol facilitates light-induced phase shifts in humans. Neuroscience Letters. 242(1). 53–56. 13 indexed citations
17.
Hampton, S., et al.. (1998). Altered postprandial hormone and metabolic responses in a simulated shift work environment. Journal of Endocrinology. 158(3). 305–310. 124 indexed citations
18.
Deacon, Steve. (1996). Adapting to phase shifts, II. Effects of melatonin and conflicting light treatment. Physiology & Behavior. 59(4-5). 675–682. 39 indexed citations
19.
Hampton, S., Linda Morgan, Natalia Lawrence, et al.. (1996). Postprandial hormone and metabolic responses in simulated shift work. Journal of Endocrinology. 151(2). 259–267. 123 indexed citations
20.
Deacon, Steve, J. English, & Joséphine Arendt. (1994). Acute phase-shifting effects of melatonin associated with suppression of core body temperature in humans. Neuroscience Letters. 178(1). 32–34. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026